FERRARI LOUIS 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 13, 2012
Insider Transaction Report
Form 4
FERRARI LOUIS
SVP, North American Commerical
Transactions
- Award
Common Stock, $.01 par value per share
2012-02-01$2.26/sh+310,000$700,600→ 354,603 total - Award
Common Stock, $.01 par value per share
2011-11-30$2.13/sh+381$812→ 44,603 total - Award
Common Stock, $.01 par value per share
2011-08-31$3.66/sh+222$813→ 44,222 total - Award
Option to Purchase Common Stock, $.01 par value
2012-02-01$2.26/sh+100,000$226,000→ 100,000 totalExercise: $2.26From: 2013-02-01Exp: 2022-02-01→ Common Stock, $.01 par value per share (100,000 underlying)
Footnotes (3)
- [F1]The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.
- [F2]Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported.
- [F3]These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates.